Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000506120 | SCV000604348 | benign | not specified | 2017-03-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001189161 | SCV001356391 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-06-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001430861 | SCV001633607 | likely benign | Aortic aneurysm, familial thoracic 4 | 2022-05-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000641618 | SCV002008254 | likely benign | not provided | 2020-11-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001189161 | SCV002638415 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-10-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |